Today
-0.94%
5 Days
-5.04%
1 Month
-4.71%
6 Months
+24.62%
Year to Date
+12.46%
1 Year
+11.43%
• Amphenol shares declined due to sector-wide profit-taking and institutional portfolio rebalancing. • Technical indicators show a MACD sell signal and a Williams %R sell condition. • The company generated $23.09B in annual revenue and $4.27B in net profit.
• Amphenol shares declined amid broader tech sector weakness and profit-taking. • Insiders sold shares, while investors scrutinized valuation and acquisition overhead. • The stock exhibits neutral technical indicators with annual revenue of $23.09B.
• Amphenol's stock rose due to institutional buying driven by AI infrastructure demand. • The company reported annual revenue of $23.09 billion and net profit of $4.27 billion. • Analysts maintain Buy ratings with an average price target of $106.55.
• Amphenol shares advanced due to institutional demand and AI infrastructure enthusiasm. • Goldman Sachs added Amphenol to its US Conviction List with a Buy rating. • The company reported record revenue and earnings exceeding consensus expectations.
• Third-quarter financial results and fourth-quarter guidance surpassed consensus expectations. • Explosive organic demand in the IT datacom market drove growth. • Amphenol announced a dividend increase and share repurchase authorization.
• Goldman Sachs added Amphenol to its US Conviction List with a Buy rating. • Third-quarter sales and earnings surpassed estimates, driven by strong IT Datacom growth. • The company authorized a new four-billion-dollar share repurchase program and increased dividends.
Amphenol (APH) Q3 2026 Earnings Call: AI Drives 77% Organic IT Datacom Growth


| Shareholders | Proportion |
|---|---|
| Fidelity Management & Research Company LLC | 6.77% |
| Vanguard Capital Management, LLC | 6.49% |
| BlackRock Institutional Trust Company, N.A. | 5.69% |
| State Street Investment Management (US) | 4.63% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 58.92% |
| Investment Advisor/Hedge Fund | 28.75% |
| Research Firm | 3.07% |
| Pension Fund | 2.85% |
Related Instruments